Bulk and single-cell transcriptomic analyses identify PNPT1 as a candidate diagnostic biomarker elevated in tumor-derived epithelial cells in esophageal cancer
Frontiers in Bioinformatics · 16.11.2026 · 6
DOI: 10.3389/fbinf.2026.1979986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioinformatics, online erschienen am 16.11.2026. Verfasst von Ahmed Mohammed Adam und 2 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
PNPT1 encodes PNPase, a mitochondrial exoribonuclease involved in RNA import and degradation. Its expression pattern in esophageal cancer (ESCA), however, remains insufficiently characterized. We assessed PNPT1 across cancer types using TIMER, GEPIA and UALCAN, then examined its diagnostic performance in TCGA-ESCA (184 tumors and 13 normal samples, with analyses stratified by histology) and an independent series of 179 paired esophageal squamous cell carcinoma (ESCC) tumor and normal samples (GSE53625). To investigate the cellular source of the observed signal, we reanalyzed two public single-cell RNA-sequencing cohorts comprising nine patients, using patient-level pseudobulk comparisons and copy-number inference where sufficient normal epithelium was available. PNPT1 differed significantly between tumor and normal tissue in 17 cancer types and was higher in tumors in 13, including ESCA. In TCGA-ESCA, the area under the receiver operating characteristic curve (AUC) was 0.951 (95% CI 0.909–0.984); however, the dataset contained far fewer normal samples than tumors, and cross-validated specificity was 92%. In the balanced esophageal squamous cell carcinoma cohort, the AUC was 0.895 (95% CI 0.867–0.920). Neither cohort showed an association between PNPT1 and overall survival using a median expression split. At single-cell resolution, PNPT1 was higher in tumor-derived than in normal epithelial cells in all three patients with paired tissues. This difference was also observed within G1-phase cells in the two evaluable patients, although patient-level tests were not statistically significant. Copy-number inference in two patients provided only partial support for the marker-based cell classification. These computational findings nominate PNPT1 as a candidate diagnostic marker for esophageal cancer, but independent clinical and experimental validation is needed.
Zitieren
APA
Adam, A. M., Ali, E. M. M., & Alzahrani, F. A. (2026). Bulk and single-cell transcriptomic analyses identify PNPT1 as a candidate diagnostic biomarker elevated in tumor-derived epithelial cells in esophageal cancer. Frontiers in Bioinformatics, 6. https://doi.org/10.3389/fbinf.2026.1979986
Vancouver
Adam AM, Ali EMM, Alzahrani FA. Bulk and single-cell transcriptomic analyses identify PNPT1 as a candidate diagnostic biomarker elevated in tumor-derived epithelial cells in esophageal cancer. Frontiers in Bioinformatics. 2026;6. doi:10.3389/fbinf.2026.1979986
BibTeX
@article{Adam2026,
author = {Adam, Ahmed Mohammed and Ali, Ehab M. M. and Alzahrani, Faisal A.},
title = {Bulk and single-cell transcriptomic analyses identify PNPT1 as a candidate diagnostic biomarker elevated in tumor-derived epithelial cells in esophageal cancer},
journal = {Frontiers in Bioinformatics},
year = {2026},
volume = {6},
doi = {10.3389/fbinf.2026.1979986}
}
EUVIMED